TCMD TACTILE SYSTEMS TECHNOLOGY INC
Nasdaq · SEC CIK 1027838 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.02M 9 sales by 3 insiders
- Filings on record
- 105 since 2021-07-07, latest 2026-08-12 16:22
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Dodd Sheri Louise | CEO, Dir | — | $1.07M |
| Birkemeyer Elaine M. | CFO | — | $492.4K |
| Burns Kristie | SVP Mktg, Clinical Affairs | — | $454.6K |
| King Laura G. | Dir | — | — |
| Washington Boyd Vindell | Dir | — | — |
| Asbury Valerie L. | Dir | — | — |
| Shafer David Brent | Dir | — | — |
| Huggenberger Raymond | Dir | — | — |
| Pearson Andrea | Dir | — | — |
| Volkart Carmen B | Dir | — | — |
Transactions 122
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 16:22 | 2026-08-10 | TCMD | Dodd Sheri Louise | CEO, Dir | S - Sale | $29.44 | -11.0K | 232.9K | -5% | -$323.2K | |
| 2026-05-13 17:01 | 2026-05-11 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $24.49 | -4,631 | 130.2K | -3% | -$113.4K | |
| 2026-05-08 17:31 | 2026-05-06 | TCMD | Asbury Valerie L. | Dir | A - Grant | $0.00 | +6,521 | 55.3K | +13% | $0 | |
| 2026-05-08 17:31 | 2026-05-06 | TCMD | Huggenberger Raymond | Dir | A - Grant | $0.00 | +6,521 | 62.8K | +12% | $0 | |
| 2026-05-08 17:31 | 2026-05-06 | TCMD | King Laura G. | Dir | A - Grant | $0.00 | +6,521 | 25.6K | +34% | $0 | |
| 2026-05-08 17:30 | 2026-05-06 | TCMD | Pearson Andrea | Dir | A - Grant | $0.00 | +6,521 | 7,373 | +765% | $0 | |
| 2026-05-08 17:29 | 2026-05-06 | TCMD | Shafer David Brent | Dir | A - Grant | $0.00 | +6,521 | 55.3K | +13% | $0 | |
| 2026-05-08 17:29 | 2026-05-06 | TCMD | Volkart Carmen B | Dir | A - Grant | $0.00 | +6,521 | 44.2K | +17% | $0 | |
| 2026-05-08 17:28 | 2026-05-06 | TCMD | Washington Boyd Vindell | Dir | A - Grant | $0.00 | +6,521 | 41.8K | +19% | $0 | |
| 2026-05-08 17:28 | 2026-05-06 | TCMD | BURKE WILLIAM W | Dir | A - Grant | $0.00 | +6,521 | 55.0K | +13% | $0 | |
| 2026-03-11 | 2026-03-09 | TCMD | Pearson Andrea | Dir | A - Grant | $0.00 | +852 | 852 | New | $0 | |
| 2026-02-26 | 2026-02-24 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.94 | -6,246 | 82.6K | -7% | -$180.8K | |
| 2026-02-26 | 2026-02-24 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $28.94 | -7,701 | 134.8K | -5% | -$222.9K | |
| 2026-02-26 | 2026-02-24 | TCMD | Dodd Sheri Louise | CEO, Dir | S - Sale | $28.94 | -11.0K | 243.9K | -4% | -$318.1K | |
| M | 2026-02-24 | 2026-02-23 | TCMD | Dodd Sheri Louise | CEO, Dir | S - Sale | $28.29 | -15.2K | 254.9K | -6% | -$431.2K |
| M | 2026-02-24 | 2026-02-20 | TCMD | Dodd Sheri Louise | CEO, Dir | A - Grant | $0.00 | +48.0K | 241.9K | +25% | $0 |
| M | 2026-02-24 | 2026-02-20 | TCMD | Birkemeyer Elaine M. | CFO | A - Grant | $0.00 | +25.9K | 148.0K | +21% | $0 |
| M | 2026-02-24 | 2026-02-23 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $28.29 | -5,518 | 142.5K | -4% | -$156.1K |
| M | 2026-02-24 | 2026-02-23 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.29 | -4,439 | 88.8K | -5% | -$125.6K |
| M | 2026-02-24 | 2026-02-20 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | A - Grant | $0.00 | +14.7K | 82.1K | +22% | $0 |
| 2026-02-23 | 2026-02-19 | TCMD | Dodd Sheri Louise | CEO, Dir | A - Grant | $0.00 | +48.7K | 222.2K | +28% | $0 | |
| 2026-02-23 | 2026-02-19 | TCMD | Birkemeyer Elaine M. | CFO | A - Grant | $0.00 | +23.0K | 122.1K | +23% | $0 | |
| 2026-02-23 | 2026-02-19 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | A - Grant | $0.00 | +6,194 | 78.6K | +9% | $0 | |
| 2026-01-06 | 2026-01-02 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.85 | -5,139 | 72.4K | -7% | -$148.3K | |
| 2025-08-12 | 2025-08-08 | TCMD | Dodd Sheri Louise | CEO, Dir | S - Sale | $12.36 | -7,762 | 173.5K | -4% | -$95.9K | |
| 2025-05-14 | 2025-05-12 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $9.94 | -2,921 | 99.1K | -3% | -$29.0K | |
| 2025-05-12 | 2025-05-08 | TCMD | Dodd Sheri Louise | CEO, Dir | S - Sale | $9.83 | -3,149 | 181.2K | -2% | -$31.0K | |
| 2025-05-09 | 2025-05-08 | TCMD | BURKE WILLIAM W | Dir | S - Sale | $9.67 | -3,300 | 48.5K | -6% | -$31.9K | |
| 2025-05-09 | 2025-05-07 | TCMD | BURKE WILLIAM W | Dir | A - Grant | $0.00 | +16.1K | 51.8K | +45% | $0 | |
| 2025-05-09 | 2025-05-07 | TCMD | Volkart Carmen B | Dir | A - Grant | $0.00 | +16.1K | 37.7K | +74% | $0 | |
| 2025-05-09 | 2025-05-07 | TCMD | Huggenberger Raymond | Dir | A - Grant | $0.00 | +16.1K | 56.3K | +40% | $0 | |
| 2025-05-09 | 2025-05-07 | TCMD | King Laura G. | Dir | A - Grant | $0.00 | +16.1K | 19.0K | +541% | $0 | |
| 2025-05-09 | 2025-05-07 | TCMD | Asbury Valerie L. | Dir | A - Grant | $0.00 | +16.1K | 48.8K | +49% | $0 | |
| 2025-05-09 | 2025-05-07 | TCMD | Shafer David Brent | Dir | A - Grant | $0.00 | +16.1K | 48.8K | +49% | $0 | |
| 2025-05-09 | 2025-05-07 | TCMD | Washington Boyd Vindell | Dir | A - Grant | $0.00 | +16.1K | 35.2K | +84% | $0 | |
| I | 2025-03-13 | 2025-03-11 | TCMD | REUVERS DANIEL L. | Dir | G - Gift | $0.00 | +68.2K | 68.2K | New | $0 |
| 2025-03-13 | 2025-03-11 | TCMD | REUVERS DANIEL L. | Dir | G - Gift | $0.00 | -68.2K | 146.4K | -32% | $0 | |
| 2025-02-27 | 2025-02-25 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $14.51 | -2,066 | 102.0K | -2% | -$30.0K | |
| 2025-02-27 | 2025-02-25 | TCMD | REUVERS DANIEL L. | Dir | S - Sale | $14.18 | -28.3K | 214.6K | -12% | -$401.8K | |
| 2025-02-27 | 2025-02-25 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $14.40 | -6,468 | 77.5K | -8% | -$93.1K | |
| 2025-02-24 | 2025-02-24 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $14.65 | -4,830 | 84.0K | -5% | -$70.8K | |
| M | 2025-02-24 | 2025-02-20 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | A - Grant | $0.00 | +24.1K | 72.3K | +50% | $0 |
| 2025-02-24 | 2025-02-24 | TCMD | REUVERS DANIEL L. | Dir | S - Sale | $14.55 | -10.9K | 242.9K | -4% | -$159.1K | |
| 2025-02-24 | 2025-02-20 | TCMD | REUVERS DANIEL L. | Dir | A - Grant | $0.00 | +15.9K | 253.9K | +7% | $0 | |
| M | 2025-02-24 | 2025-02-20 | TCMD | Dodd Sheri Louise | CEO, Dir | A - Grant | $0.00 | +85.8K | 184.4K | +87% | $0 |
| 2025-02-24 | 2025-02-20 | TCMD | King Laura G. | Dir | A - Grant | $0.00 | +2,970 | 2,970 | New | $0 | |
| 2025-02-24 | 2025-02-24 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $14.70 | -3,778 | 104.1K | -4% | -$55.5K | |
| M | 2025-02-24 | 2025-02-20 | TCMD | Birkemeyer Elaine M. | CFO | A - Grant | $0.00 | +46.6K | 71.6K | +186% | $0 |
| 2024-08-14 | 2024-08-12 | TCMD | Ferstler Sherri Lee | Senior VP, Sales | S - Sale | $13.07 | -1,550 | 38.8K | -4% | -$20.3K | |
| 2024-08-09 | 2024-08-07 | TCMD | Dodd Sheri Louise | CEO, Dir | A - Grant | $0.00 | +65.0K | 98.6K | +193% | $0 | |
| 2024-05-20 | 2024-05-16 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $13.68 | -3,041 | 61.3K | -5% | -$41.6K | |
| 2024-05-10 | 2024-05-08 | TCMD | Asbury Valerie L. | Dir | A - Grant | $0.00 | +10.5K | 32.7K | +47% | $0 | |
| 2024-05-10 | 2024-05-08 | TCMD | Huggenberger Raymond | Dir | A - Grant | $0.00 | +10.5K | 40.2K | +35% | $0 | |
| 2024-05-10 | 2024-05-08 | TCMD | BURKE WILLIAM W | Dir | A - Grant | $0.00 | +10.5K | 35.7K | +41% | $0 | |
| 2024-05-10 | 2024-05-08 | TCMD | BURKE WILLIAM W | Dir | S - Sale | $14.06 | -2,500 | 25.3K | -9% | -$35.1K | |
| 2024-05-10 | 2024-05-08 | TCMD | Dodd Sheri Louise | Dir | A - Grant | $0.00 | +10.5K | 33.7K | +45% | $0 | |
| 2024-05-10 | 2024-05-08 | TCMD | Volkart Carmen B | Dir | A - Grant | $0.00 | +10.5K | 21.6K | +94% | $0 | |
| 2024-05-10 | 2024-05-08 | TCMD | Shafer David Brent | Dir | A - Grant | $0.00 | +10.5K | 32.7K | +47% | $0 | |
| 2024-05-10 | 2024-05-08 | TCMD | Washington Boyd Vindell | Dir | A - Grant | $0.00 | +10.5K | 19.2K | +120% | $0 | |
| 2024-05-08 | 2024-05-06 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $14.37 | -815 | 62.6K | -1% | -$11.7K | |
| M | 2024-02-29 | 2024-02-27+ | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | S - Sale | $15.52 | -6,085 | 238.0K | -2% | -$94.4K |
| M | 2024-02-29 | 2024-02-27+ | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $15.52 | -1,334 | 63.4K | -2% | -$20.7K |
| M | 2024-02-27 | 2024-02-23+ | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | S - Sale | $15.37 | -11.6K | 244.1K | -5% | -$178.5K |
| M | 2024-02-27 | 2024-02-24 | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | A - Grant | $0.00 | +58.0K | 237.3K | +32% | $0 |
| 2024-02-27 | 2024-02-24 | TCMD | Birkemeyer Elaine M. | CFO | A - Grant | $0.00 | +2,848 | 64.3K | +5% | $0 | |
| M | 2024-02-27 | 2024-02-23+ | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $15.32 | -4,264 | 63.5K | -6% | -$65.3K |
| M | 2024-02-27 | 2024-02-24 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | A - Grant | $0.00 | +11.8K | 62.8K | +23% | $0 |
| 2024-02-23 | 2024-02-21 | TCMD | Birkemeyer Elaine M. | CFO | A - Grant | $0.00 | +32.4K | 61.5K | +112% | $0 | |
| 2024-02-23 | 2024-02-21 | TCMD | Ferstler Sherri Lee | Senior VP, Sales | A - Grant | $0.00 | +21.6K | 40.3K | +116% | $0 | |
| 2024-02-23 | 2024-02-21 | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | A - Grant | $0.00 | +72.0K | 197.7K | +57% | $0 | |
| 2024-02-23 | 2024-02-21 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | A - Grant | $0.00 | +19.5K | 56.0K | +53% | $0 | |
| 2023-11-13 | 2023-11-08 | TCMD | Washington Boyd Vindell | Dir | A - Grant | $0.00 | +8,700 | 8,700 | New | $0 | |
| 2023-08-11 | 2023-08-09 | TCMD | Ferstler Sherri Lee | Senior VP, Sales | A - Grant | $0.00 | +18.7K | 18.7K | New | $0 | |
| 2023-08-09 | 2023-08-07 | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | S - Sale | $20.53 | -1,062 | 125.7K | -0.8% | -$21.8K | |
| 2023-05-16 | 2023-05-12 | TCMD | BURKE WILLIAM W | Dir | S - Sale | $21.86 | -4,400 | 27.8K | -14% | -$96.2K | |
| 2023-05-11 | 2023-05-10 | TCMD | Birkemeyer Elaine M. | CFO | A - Grant | $0.00 | +29.1K | 29.1K | New | $0 | |
| 2023-05-10 | 2023-05-08 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $18.65 | -786 | 36.6K | -2% | -$14.7K | |
| 2023-05-10 | 2023-05-08 | TCMD | Volkart Carmen B | Dir | A - Grant | $0.00 | +7,737 | 11.2K | +227% | $0 | |
| 2023-05-10 | 2023-05-08 | TCMD | Shafer David Brent | Dir | A - Grant | $0.00 | +7,737 | 22.3K | +53% | $0 | |
| 2023-05-10 | 2023-05-08 | TCMD | BURKE WILLIAM W | Dir | A - Grant | $0.00 | +7,737 | 32.2K | +32% | $0 | |
| 2023-05-10 | 2023-05-08 | TCMD | Dodd Sheri Louise | Dir | A - Grant | $0.00 | +7,737 | 23.2K | +50% | $0 | |
| 2023-05-10 | 2023-05-08 | TCMD | Huggenberger Raymond | Dir | A - Grant | $0.00 | +7,737 | 29.8K | +35% | $0 | |
| 2023-05-10 | 2023-05-08 | TCMD | PAULS ERIC | Senior VP, Sales | S - Sale | $18.55 | -550 | 29.5K | -2% | -$10.2K | |
| 2023-05-10 | 2023-05-08 | TCMD | Asbury Valerie L. | Dir | A - Grant | $0.00 | +7,737 | 22.3K | +53% | $0 | |
| 2023-03-03 | 2023-03-01 | TCMD | Moen Brent | CFO | S - Sale | $14.10 | -1,391 | 48.8K | -3% | -$19.6K | |
| M | 2023-02-28 | 2023-02-27+ | TCMD | Moen Brent | CFO | S - Sale | $15.31 | -4,052 | 50.4K | -7% | -$62.0K |
| 2023-02-28 | 2023-02-25 | TCMD | Moen Brent | CFO | A - Grant | $0.00 | +2,304 | 54.2K | +4% | $0 | |
| M | 2023-02-28 | 2023-02-27+ | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $15.34 | -2,297 | 37.5K | -6% | -$35.2K |
| 2023-02-28 | 2023-02-25 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | A - Grant | $0.00 | +962 | 39.6K | +2% | $0 | |
| M | 2023-02-28 | 2023-02-27+ | TCMD | PAULS ERIC | Senior VP, Sales | S - Sale | $15.29 | -1,473 | 30.0K | -5% | -$22.5K |
| 2023-02-28 | 2023-02-25 | TCMD | PAULS ERIC | Senior VP, Sales | A - Grant | $0.00 | +595 | 31.5K | +2% | $0 | |
| 2023-02-28 | 2023-02-25 | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | A - Grant | $0.00 | +6,482 | 133.8K | +5% | $0 | |
| M | 2023-02-28 | 2023-02-27+ | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | S - Sale | $15.20 | -7,087 | 126.7K | -5% | -$107.7K |
| 2023-02-24 | 2023-02-22 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | A - Grant | $0.00 | +16.7K | 38.7K | +76% | $0 | |
| 2023-02-24 | 2023-02-22 | TCMD | Volkart Carmen B | Dir | A - Grant | $0.00 | +3,414 | 3,414 | New | $0 | |
| 2023-02-24 | 2023-02-22 | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | A - Grant | $0.00 | +52.6K | 127.3K | +70% | $0 | |
| 2023-02-24 | 2023-02-22 | TCMD | PAULS ERIC | Senior VP, Sales | A - Grant | $0.00 | +12.6K | 30.9K | +69% | $0 | |
| 2022-08-10 | 2022-08-08 | TCMD | REUVERS DANIEL L. | Pres, CEO, Dir | S - Sale | $9.18 | -1,020 | 74.7K | -1% | -$9,364 | |
| 2022-08-08 | 2022-08-04 | TCMD | BURKE WILLIAM W | Dir | P - Purchase | $9.15 | +4,900 | 24.4K | +25% | +$44.8K | |
| 2022-05-23 | 2022-05-19 | TCMD | BURKE WILLIAM W | Dir | S - Sale | $10.12 | -1,100 | 19.5K | -5% | -$11.1K |
Purchase Sale Sale after option exercise All abbreviations